Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026)
Stereotaxis (STXS) posted quarterly Other Non-Current Liabilities of $5.1 million for Q1 2026, down 18.38% year-over-year from $6.3 million in Q1 2025, and up 8.13% quarter-over-quarter from $4.7 million in Q4 2025.
Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Other Non-Current Liabilities for 17 consecutive years, with $5.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 18.38% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $5.1 million (down 18.38% YoY), while the FY2025 annual figure was $4.7 million, down 22.89% from the prior year.
- Other Non-Current Liabilities advanced to $5.1 million in Q1 2026 per STXS's latest filing, from $4.7 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $6.3 million in Q1 2025 and bottomed at $43000.0 in Q2 2023.
- Historically, Other Non-Current Liabilities has averaged $1.5 million across 5 years, with a median of $168000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities sank 78.71% — and 2025, when it surged 14453.49%.
- Stereotaxis' Other Non-Current Liabilities stood at $51000.0 in 2022, then retreated by 15.69% to $43000.0 in 2023, then soared by 14146.51% to $6.1 million in 2024, then dropped by 22.89% to $4.7 million in 2025, then advanced by 8.13% to $5.1 million in 2026.
- Business Quant data shows STXS's Other Non-Current Liabilities at $5.1 million in Q1 2026, $4.7 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.11 Mn |
| Dec 31, 2025 | 4.72 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 6.26 Mn |
| Dec 31, 2024 | 6.13 Mn |
| Sep 30, 2024 | 55,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 51,000.00 |
| Sep 30, 2022 | 168,000.00 |
| Jun 30, 2022 | 202,000.00 |
| Mar 31, 2022 | 202,000.00 |
| Dec 31, 2021 | 218,000.00 |
| Sep 30, 2021 | 215,861.00 |
| Jun 30, 2021 | 206,596.00 |